Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Sci Data ; 11(1): 511, 2024 May 17.
Article in English | MEDLINE | ID: mdl-38760409

ABSTRACT

The development of successful artificial intelligence models for chest X-ray analysis relies on large, diverse datasets with high-quality annotations. While several databases of chest X-ray images have been released, most include disease diagnosis labels but lack detailed pixel-level anatomical segmentation labels. To address this gap, we introduce an extensive chest X-ray multi-center segmentation dataset with uniform and fine-grain anatomical annotations for images coming from five well-known publicly available databases: ChestX-ray8, CheXpert, MIMIC-CXR-JPG, Padchest, and VinDr-CXR, resulting in 657,566 segmentation masks. Our methodology utilizes the HybridGNet model to ensure consistent and high-quality segmentations across all datasets. Rigorous validation, including expert physician evaluation and automatic quality control, was conducted to validate the resulting masks. Additionally, we provide individualized quality indices per mask and an overall quality estimation per dataset. This dataset serves as a valuable resource for the broader scientific community, streamlining the development and assessment of innovative methodologies in chest X-ray analysis.


Subject(s)
Radiography, Thoracic , Humans , Databases, Factual , Artificial Intelligence , Lung/diagnostic imaging
2.
JHEP Rep ; 6(3): 100985, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38384670

ABSTRACT

Background & Aims: Malnutrition, sarcopenia, and frailty are prevalent in cirrhosis. We aimed to assess the correlation between assessment tools for malnutrition, sarcopenia, and frailty in patients on the liver transplant (LT) waiting list (WL), and to identify a predictive model for acute-on-chronic liver failure (ACLF) development. Methods: This prospective single-center study enrolled consecutive patients with cirrhosis on the WL for LT (May 2019-November 2021). Assessments included subjective global assessment, CT body composition, skeletal muscle index (SMI), ultrasound thigh muscle thickness, sarcopenia HIBA score, liver frailty index (LFI), hand grip strength, and 6-minute walk test at enrollment. Correlations were analyzed using Pearson's correlation. Competing risk regression analysis was used to assess the predictive ability of the liver- and functional physiological reserve-related variables for ACLF. Results: A total of 132 patients, predominantly with decompensated cirrhosis (87%), were included. Our study revealed a high prevalence of malnutrition (61%), sarcopenia (61%), visceral obesity (20%), sarcopenic visceral obesity (17%), and frailty (10%) among participants. Correlations between the assessment tools for sarcopenia and frailty were poor. Sarcopenia by SMI remained prevalent when frailty assessments were not usable. After a median follow-up of 10 months, 39% of the patients developed ACLF on WL, while 28% experienced dropouts without ACLF. Multivariate analysis identified MELD-Na, SMI, and LFI as independent predictors of ACLF on the WL. The predictive model MELD-Na-sarcopenia-LFI had a C-statistic of 0.85. Conclusions: The poor correlation between sarcopenia assessment tools and frailty underscores the importance of a comprehensive evaluation. The SMI, LFI, and MELD-Na independently predicted ACLF development in WL. These findings enhance our understanding of the relationship between sarcopenia, frailty, and ACLF in patients awaiting LT, emphasizing the need for early detection and intervention to improve WL outcomes. Impact and implications: The relationship between sarcopenia and frailty assessment tools, as well as their ability to predict acute-on-chronic liver failure (ACLF) in patients on the liver transplant (LT) waiting list (WL), remains poorly understood. Existing objective frailty screening tests have limitations when applied to critically ill patients. The correlation between sarcopenia and frailty assessment tools was weak, suggesting that they may capture different phenotypes. Sarcopenia assessed by skeletal muscle index, frailty evaluated using the liver frailty index, and the model for end-stage liver disease-Na score independently predicted the development of ACLF in patients on the WL. Our findings support the integration of liver frailty index and skeletal muscle index assessments at the time of inclusion on the WL for LT. This combined approach allows for the identification of a specific patient subgroup with an increased susceptibility to ACLF, underscoring the importance of early implementation of targeted treatment strategies to improve outcomes for patients awaiting LT.

3.
Hepatol Commun ; 6(7): 1699-1710, 2022 07.
Article in English | MEDLINE | ID: mdl-35238487

ABSTRACT

Sarcopenia is a prevalent condition that predicts prognosis in patients awaiting liver transplantation (LT). The gold standard for the diagnosis of sarcopenia is the assessment of the muscular area at L3 with computed tomography (CT) scan (skeletal muscle index [SMI]), but the routine use of CT scan is limited in clinical practice. Thus, we designed a single-center observational study aimed to evaluate the clinical factors associated with the presence of sarcopenia by SMI, and to build a score capable of predicting or excluding the presence of sarcopenia in patients on the LT waiting list (WL). Binary logistic regression analysis was performed to establish the factors independently associated with sarcopenia, and the Sarcopenia Hospital Italiano de Buenos Aires (HIBA) score was built from the resulting model after internal validation analysis by bootstrapping and correction for optimism. The predictive capability of mortality on the WL was evaluated with competing risk regression analysis. A total of 215 patients with cirrhosis on the LT WL were included. The independent factors associated with the presence of sarcopenia were male sex (odds ratio [OR]: 6.09, p < 0.001), body mass index (OR: 0.74, p < 0.001), Child Pugh (OR: 1.44, p < 0.001), and the ratio creatinine/Cystatin C (OR: 0.03, p = 0.007). The Sarcopenia HIBA score constructed with these variables showed an area under the curve of 0.862. During follow-up, 77 (36%) patients underwent LT, 46 (21%) died, and 92 (43%) remained alive. After adjusting for Model for End-Stage Liver Disease-Sodium, Sarcopenia HIBA score was an independent predictor of WL mortality (subhazard ratio: 1.19; 95% confidence interval 1.01-1.40; p = 0.042). Sarcopenia HIBA score is an easy-to-use, objective, and reliable diagnostic and predictive tool that can be useful to improve the prognostic evaluation and allow identifying a group of patients with a higher risk of death while awaiting LT.


Subject(s)
End Stage Liver Disease , Liver Transplantation , Sarcopenia , End Stage Liver Disease/complications , Female , Hospitals , Humans , Liver Transplantation/adverse effects , Male , Retrospective Studies , Sarcopenia/diagnosis , Severity of Illness Index , Waiting Lists
4.
J Ultrasound ; 25(2): 409-412, 2022 Jun.
Article in English | MEDLINE | ID: mdl-34145533

ABSTRACT

The aim of this paper is to describe the distinctive ultrasound findings of a case of vaginal bleeding caused by the presence of a foreign body. We present the case of an infant who consulted for vaginal bleeding and foul-smelling discharge. The ultrasound revealed signs of vaginal distension due to heterogeneous-hematic contents and parietal thickening. At Doppler examination, a striking finding of increased vascularization limited to the upper two-thirds of the vaginal wall was found, which was initially interpreted as a sign of local inflammation suggesting the presence of an underlying foreign body. At direct vaginoscopic examination remains of toilet paper in the vaginal fundus were found. The presence of a foreign body in the vagina is an uncommon cause of discharge and vaginal bleeding in pediatrics, therefore, this etiology should be kept in mind when the adequate clinical context arises. Doppler ultrasound represents a first-line complementary method when this entity is suspected.


Subject(s)
Foreign Bodies , Vaginal Diseases , Child , Female , Foreign Bodies/diagnostic imaging , Humans , Ultrasonography/adverse effects , Uterine Hemorrhage/complications , Uterine Hemorrhage/etiology , Vagina/diagnostic imaging , Vaginal Diseases/etiology
5.
Rev. argent. radiol ; 86(3): 199-210, 2022. tab, graf
Article in Spanish | LILACS, BINACIS | ID: biblio-1407209

ABSTRACT

Resumen El derrame pericárdico (DP) es una entidad frecuente en la práctica diaria, que puede ocurrir por un amplio rango de patologías. Los métodos por imágenes constituyen una herramienta diagnóstica clave en la evaluación del pericardio. El ecocardiograma transtorácico (ETT) se considera de primera línea por su costo-efectividad. La tomografía computarizada multicorte (TCMC), por su parte, representa un valioso complemento ante limitaciones del ETT y en la evaluación de urgencia del paciente con sospecha de DP. El objetivo del trabajo es mostrar la utilidad y rol de la TCMC, mediante la medición de densidades, para estimar la etiología del DP, ilustrado con casos de nuestra institución.


Abstract Pericardial effusion (PE) is a common entity in daily practice, which can occur due to a wide range of conditions. Imaging methods are a key diagnostic tool in the evaluation of the pericardium. Transthoracic echocardiogram (TTE) is the first line imaging method because of its cost-effectiveness. Multi-slice Computed Tomography (MSCT), on the other hand, represents a valuable complement to the limitations of TTE and in emergency evaluation of the patient with suspected PE. The objective of this review is to show the usefulness and role of the MSCT —through the measurement of densities— to estimate the etiology of PE, illustrated with cases of our Institution.


Subject(s)
Humans , Male , Female , Pericardial Effusion , Pericardium/pathology , Pneumopericardium/diagnostic imaging , Pericardial Fluid , Pericarditis , Tomography, X-Ray Computed , Heart Failure
6.
Rev. Asoc. Argent. Ortop. Traumatol ; 85(2): 167-173, jun. 2020.
Article in Spanish | LILACS, BINACIS | ID: biblio-1125555

ABSTRACT

La displasia fibrosa es una lesión ósea benigna caracterizada por el desarrollo anormal del tejido fibroso de disposición arremolinada, con trabéculas de hueso inmaduro no laminar. Se distinguen dos formas: monostótica y poliostótica. El compromiso de columna vertebral se asocia, con más frecuencia, a la variedad poliostótica; la forma monostótica es infrecuente. Presentamos a una mujer de 46 años que consultó por lumbocruralgia derecha de dos meses de evolución, con diagnóstico definitivo de displasia fibrosa de columna lumbar. Los estudios por imágenes mostraron una lesión monostótica lítico-quística con tabiques internos localizada en el arco posterior de la quinta vértebra lumbar. Sus características en los estudios por imágenes sugirieron un quiste óseo aneurismático, mientras que la anatomía patológica fue reveladora frente al diagnóstico final de displasia fibrosa. Los síntomas menores y la ausencia de complicaciones llevaron a indicar un tratamiento conservador. Si bien el compromiso de columna lumbar por displasia fibrosa monostótica es infrecuente, debería considerarse entre los diagnósticos diferenciales de una lesión lítica solitaria en dicha localización. No obstante, no se descarta mediante histopatología que pueda tratarse de un caso de coexistencia de displasia fibrosa y quiste óseo aneurismático o que la displasia fibrosa se haya desarrollado sobre un quiste óseo aneurismático. Nivel de Evidencia: IV


Fibrous dysplasia (FD) is a benign skeletal disorder characterized by abnormal development of fibrous tissue in a whorled pattern and containing trabeculae of immature non-lamellar bone. FD has two forms of clinical presentations: monostotic and polyostotic. Spinal involvement is seen mostly in the polyostotic form and is very unusual in the monostotic form. We present a 46-year-old woman that complained of right low back pain with a 2-month evolution. The definitive diagnosis was FD of the lumbar spine. Imaging testing revealed a lytic-cystic monostotic lesion with internal septa located in the posterior arch of the fifth lumbar vertebra, suggestive of Aneurysmal Bone Cyst (ABC). However, the anatomical pathology revealed FD as the final diagnosis. Conservative treatment was undertaken due to minimal symptoms and the absence of complications. Although monostotic FD of lumbar spine is rare, it should be taken into account among the differential diagnoses of a single osteolytic lesion. However, histopathology testing cannot rule out the coexistence of FB and ABC or a setting of FB secondary to an ABC. Level of Evidence: IV


Subject(s)
Middle Aged , Spinal Diseases , Bone Cysts, Aneurysmal , Fibrous Dysplasia of Bone , Lumbar Vertebrae
7.
Transplantation ; 104(7): e188-e198, 2020 07.
Article in English | MEDLINE | ID: mdl-32150034

ABSTRACT

BACKGROUND: Cystatin C (CysC) is an early biomarker of renal dysfunction scarcely studied in patients awaiting liver transplantation (LT). Sarcopenia is frequent in cirrhosis and impacts prognosis. We aimed to assess the capability of these factors to predict survival and acute-on-chronic liver failure (ACLF) in patients awaiting LT, as well as early post-LT outcomes. METHODS: Single-center study that included all cirrhotic patients listed for LT between 2014 and 2017. Competing risk regression analysis was used to evaluate the capability of liver-, kidney-, and global status-related variables at waitlist (WL) inclusion to predict WL mortality and ACLF. Variables associated with post-LT outcomes were evaluated with logistic regression analysis. RESULTS: One-hundred-and-eighty patients were included. Fifty-six (31%) patients developed ACLF, 54 (30%) underwent LT and 35 (19%) died. In the adjusted competing risk regression analysis, CysC ≥ 1.5 mg/L, sarcopenia and MELD-Na were independent predictors of ACLF in the WL, while CysC ≥ 1.5 mg/L, sarcopenia and albumin were independent predictors of mortality. The cumulative incidence of ACLF and mortality at 12 months were 50% and 34% in patients with sarcopenia and CysC ≥1.5 mg/L. An estimated glomerular filtration rate by chronic kidney disease (CKD)-EPI-CysC-creatinine <60 mL/min/1.73 m at WL inclusion was an independent predictor of the need for renal replacement therapy (RRT) in the first month post-LT. CONCLUSIONS: Higher levels of CysC and sarcopenia are strongly associated with the ACLF and mortality in WL. The assessment of both risk factors may improve the prognostic evaluation and allow identifying a group of patients with a very high risk of poor outcomes while awaiting LT.


Subject(s)
Acute-On-Chronic Liver Failure/diagnosis , Cystatin C/blood , End Stage Liver Disease/mortality , Liver Cirrhosis/mortality , Liver Transplantation/adverse effects , Sarcopenia/embryology , Acute Kidney Injury/blood , Acute Kidney Injury/epidemiology , Acute Kidney Injury/etiology , Acute Kidney Injury/therapy , Acute-On-Chronic Liver Failure/epidemiology , Acute-On-Chronic Liver Failure/etiology , Acute-On-Chronic Liver Failure/therapy , Aged , Biomarkers/blood , Creatinine/blood , End Stage Liver Disease/blood , End Stage Liver Disease/complications , End Stage Liver Disease/diagnosis , Female , Glomerular Filtration Rate , Humans , Incidence , Liver Cirrhosis/blood , Liver Cirrhosis/complications , Liver Cirrhosis/diagnosis , Male , Middle Aged , Patient Selection , Prognosis , Renal Insufficiency, Chronic/blood , Renal Insufficiency, Chronic/epidemiology , Renal Insufficiency, Chronic/etiology , Renal Insufficiency, Chronic/therapy , Renal Replacement Therapy/statistics & numerical data , Retrospective Studies , Risk Assessment/methods , Risk Factors , Sarcopenia/blood , Sarcopenia/etiology , Severity of Illness Index , Waiting Lists/mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...